A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: Reliability and validity

Rheumatology International

Volumn 25, Issue 4, 2005, Pages 280-284

  Akkoc, Yesim ^a   Karatepe, Altinay Goksel ^a   Akar, Servet ^b   Kirazli, Yesim ^a   Akkoc, Nurullah ^b  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Ankylosing spondylitis; Assessment; Disease activity

Indexed keywords

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; EVALUATION; EXERCISE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; TURKEY (REPUBLIC); VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; CHILD; CROSS-CULTURAL COMPARISON; CULTURAL CHARACTERISTICS; EXERCISE THERAPY; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LANGUAGE; MALE; MIDDLE AGED; QUESTIONNAIRES; RANGE OF MOTION, ARTICULAR; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; TURKEY;

EID: 20044385791     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-003-0432-y     Document Type: Article

References (22)

1. Russell AS (1998) Ankylosing spondylitis: history. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby, London, pp 1-2
2. Calin A (1987) Editorial. Assessing disease activity in AS. Lancet 1:1072
3. Taylor HG, Wardle T, Beswick EJ et al (1991) The relationship of clinical and laboratory measurements to radiological change in AS. Br J Rheumatol 30:330-335
4. Calin A (1995) The individual with ankylosing spondylitis: defining disease status and impact of illness. Br J Rheumatol 34:663-672
5. Pyle KD, Laurent MR, Salmond CE, Best MJ, Pyle EA, Moloney RO (1991) Clinical assessment of ankylosing spondylitis: a study of observer variation in spinal measurements. Br J Rheumatol 30:29-34
6. Ruof J, Stucki G (1999) Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J Rheumatol 26:966-970
7. Kennedy L, Jenkinson T, Mallorie T, Whitelock H, Garrett S (1995) Ankylosing spondylitis: the correlation between a new metrology score and radiology. Br J Rheumatol 34:767-770
8. Mander M, Simpson JM, McLennan A, Walker D, Goodacre JA, Carson Dick W (1987) Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis 46:197-202
9. Kennedy LG, Edmuns L, Calin A (1993) The natural history of ankylosing spondylitis. Does it burn out? J Rheumatol 20:688-692
10. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286-2291
11. Claudepierre P, Sibilia J, Goupille P, Flipo RM, Wendling D, Eulry F, Clerc D, Berthelot JM, Vergne P, Roudot-Thoraval F, Larget-Piet B, Chevalier X (1997) Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondyloarthropathy. J Rheumatol 24:1954-1958
12. Waldner A, Cronstedt H, Stenström CH (1999) The Swedish version of Bath ankylosing spondylitis disease activity index. Reliability and validity. Scand J Rheumatol 28 [Suppl 111]:10-16
13. Brandt J, Westhoff G, Rudwaleit M, Listing J, Zink A, Braun J, Sieper J (2003) Adaptation and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in Germany. Z Rheumatol 62:264-273
14. Cardiel MH, Londono JD, Gutierrez E, Pacheco-Tena C, Vazquez-Mellado J, Burgos-Vargas R (2003) Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies. Clin Exp Rheumatol 21:451-458
15. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361-368
16. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281-2285
17. Jones SD, Steiner A, Garrett SL, Calin A (1996) The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol 35:66-71
18. Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 21:1694-1698
19. Scalapino KL, Davis JC Jr (2003) The treatment of ankylosing spondylitis. Clin Exp Med 2:159-165
20. Haywood KL, Garratt AM, Dziedzic K, Dawes PT (2002) Generic measures of health-related quality of life in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology (Oxford) 41:1380-1387
21. Maksymowych WP, Jhangri GS, Fitzgerald AA, LeClercq S, Chiu P, Yan A, Skeith KJ, Aaron SL, Homik J, Davis P, Sholter D, Russell AS (2002) A six-month randomised, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. Arthritis Rheum 46:766-773
22. Brandt J, Haibel H, Cornely D, Golder W, Gonzalez J, Reddig J, Thriene W, Sieper J, Braun J (2000) Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab. Arthritis Rheum 43:1346-1352